DR Horton Inc (DHI)
Official siteCONSUMER CYCLICAL • RESIDENTIAL CONSTRUCTION • NYSE
Market Cap: $39.51B
Last updated: Nov 17, 2026 at 11:04 AM ET
DR Horton Inc (DHI) Financials: Revenue, Profit and Cash Flow
DR Horton reported revenue of $34.25B for the fiscal year ended Sep 30, 2025, down 6.9% from the year before. That year, net income was $3.62B with a net margin of 10.6%, operating cash flow was $3.42B and free cash flow was $3.28B. The quarter ended Jun 30, 2026 had revenue of $9.23B and net income of $918.70M.
Revenue and Margins
The operating margin was 12.9% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from $12.16B, a compound annual rate of 12.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $34.25B | -6.9% | 23.7% | 12.9% | 10.6% |
| Sep 2024 | $36.80B | +3.8% | 25.9% | 16.1% | 13.1% |
| Sep 2023 | $35.46B | +5.9% | 26.4% | 17.2% | 13.5% |
| Sep 2022 | $33.48B | +20.5% | 31.4% | 22.6% | 17.6% |
| Sep 2021 | $27.77B | +36.7% | 28.4% | 19.2% | 15.1% |
| Sep 2020 | $20.31B | +15.5% | 24.3% | 14.5% | 11.7% |
| Sep 2019 | $17.59B | +9.5% | 22.0% | 11.9% | 9.2% |
| Sep 2018 | $16.07B | +14.0% | 22.8% | 12.5% | 9.1% |
| Sep 2017 | $14.09B | +15.9% | 21.6% | 11.2% | 7.4% |
| Sep 2016 | $12.16B | N/A | 21.8% | 11.0% | 7.3% |
Income Statement
In the fiscal year ended Sep 2025, net income fell 24.7% from the year before. In the quarter ended Jun 2026, net income fell 10.8% from the same quarter a year earlier.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.25B | $36.80B | $35.46B | $33.48B | $27.77B | $20.31B | $17.59B | $16.07B | $14.09B | $12.16B |
| Cost of revenue | $26.13B | $27.27B | $26.11B | $22.98B | $19.90B | $15.37B | $13.72B | $12.40B | $11.04B | $9.50B |
| Gross profit | $8.12B | $9.54B | $9.35B | $10.50B | $7.88B | $4.94B | $3.87B | $3.67B | $3.05B | $2.65B |
| Operating income | $4.42B | $5.94B | $6.10B | $7.57B | $5.33B | $2.95B | $2.09B | $2.01B | $1.58B | $1.33B |
| Net income | $3.62B | $4.81B | $4.80B | $5.90B | $4.19B | $2.38B | $1.62B | $1.46B | $1.04B | $886.30M |
| EBITDA | $4.84B | $6.37B | $6.41B | $7.71B | $5.46B | $3.07B | $2.21B | $2.13B | $1.66B | $1.42B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.23B | $7.56B | $6.89B | $9.68B | $9.23B | $7.73B | $7.61B | $10.00B | $9.97B | $9.11B | $7.73B | $10.50B |
| Gross profit | $2.15B | $1.70B | $1.59B | $2.10B | $2.21B | $1.90B | $1.91B | $2.55B | $2.64B | $2.33B | $2.01B | $2.82B |
| Operating income | $1.16B | $800.00M | $729.60M | $1.13B | $1.26B | $1.00B | $1.03B | $1.59B | $1.72B | $1.45B | $1.17B | $1.94B |
| Net income | $918.70M | $658.00M | $601.40M | $916.80M | $1.03B | $819.10M | $851.90M | $1.30B | $1.37B | $1.18B | $955.70M | $1.53B |
Balance Sheet
As of Sep 2025, total debt of $11.93B exceeded cash and equivalents by $8.95B.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $35.47B | $36.10B | $32.58B | $30.35B | $24.02B | $18.91B | $15.61B | $14.11B | $12.18B | $11.56B |
| Current assets | $28.32B | $29.45B | $26.27B | $24.23B | $19.72B | $3.04B | $12.80B | $11.90B | $10.26B | $9.65B |
| Cash and equivalents | $2.99B | $4.52B | $3.87B | $2.54B | $3.21B | $3.02B | $1.49B | $1.47B | $1.01B | $1.30B |
| Total liabilities | $10.73B | $10.28B | $9.44B | $10.57B | $8.80B | $6.79B | $5.31B | $4.96B | $4.44B | $4.77B |
| Short-term debt | $5.97B | $563.00M | $5.09B | $6.07B | $5.41B | $4.28B | $3.40B | $3.20B | $2.45B | $2.80B |
| Long-term debt | $5.97B | $5.92B | $5.09B | $6.07B | $5.41B | $4.28B | $2.51B | $3.20B | $2.87B | $3.27B |
| Shareholder equity | $24.19B | $25.31B | $22.70B | $19.40B | $14.89B | $11.84B | $10.02B | $8.98B | $7.75B | $6.79B |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $36.51B | $35.57B | $34.64B | $35.47B | $36.40B | $35.69B | $35.03B | $36.10B | $35.15B | $34.40B | $33.38B | $32.58B |
| Total liabilities | $12.10B | $11.37B | $10.08B | $10.73B | $11.80B | $10.83B | $9.57B | $10.28B | $10.00B | $10.10B | $9.78B | $9.44B |
| Cash and equivalents | $2.08B | $1.92B | $2.51B | $2.99B | $2.61B | $2.47B | $3.05B | $4.52B | $2.99B | $3.06B | $3.32B | $3.87B |
| Shareholder equity | $23.82B | $23.63B | $24.00B | $24.19B | $24.05B | $24.33B | $24.94B | $25.31B | $24.66B | $23.82B | $23.15B | $22.70B |
Cash Flow
In the fiscal year ended Sep 2025, free cash flow was 95.9% of operating cash flow. Dividends and share repurchases together came to 145.7% of it.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.42B | $2.19B | $4.30B | $561.80M | $534.40M | $1.42B | $892.10M | $545.20M | $440.20M | $623.90M |
| Capital expenditures | $137.40M | $165.30M | $148.60M | $148.20M | $267.40M | $286.80M | $224.10M | $138.30M | $157.30M | $86.10M |
| Free cash flow | $3.28B | $2.02B | $4.16B | $413.60M | $267.00M | $1.13B | $668.00M | $406.90M | $282.90M | $537.80M |
| Dividends paid | $494.80M | $395.20M | $341.20M | $316.50M | $289.30M | $256.00M | $227.30M | $191.60M | $149.60M | $118.70M |
| Share repurchases | $4.28B | $1.79B | $1.18B | $1.13B | $848.40M | $360.40M | $479.80M | $127.50M | $60.60M | $0 |
| Investing cash flow | -$168.70M | -$190.60M | -$310.20M | -$414.90M | -$252.20M | -$166.10M | -$394.00M | $19.00M | -$164.00M | -$112.60M |
| Financing cash flow | -$4.76B | -$1.36B | -$2.67B | -$811.20M | -$85.10M | $270.60M | -$490.10M | -$82.50M | -$564.60M | -$591.90M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $439.30M | -$412.50M | $854.00M | $2.47B | $738.60M | -$436.20M | $646.70M | $1.96B | $698.30M | -$316.70M | -$153.40M | $2.04B |
| Capital expenditures | $42.00M | $37.20M | $27.40M | $43.80M | $46.00M | $34.30M | $13.30M | $32.00M | $62.00M | $23.70M | $47.60M | $40.30M |
| Free cash flow | $397.30M | -$449.70M | $826.60M | $2.43B | $692.60M | -$470.50M | $633.40M | $1.93B | $636.30M | -$340.40M | -$201.00M | $2.00B |
Frequently Asked Questions About DHI
What is DR Horton's annual revenue?
DR Horton reported revenue of $34.25B for the fiscal year ended Sep 30, 2025.
How fast is DR Horton's revenue growing?
Revenue was down 6.9% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.8%.
Is DR Horton profitable?
Yes. DR Horton reported net income of $3.62B for the fiscal year ended Sep 30, 2025, with a net margin of 10.6%.
How much free cash flow does DHI generate?
For the fiscal year ended Sep 30, 2025, operating cash flow of $3.42B minus capital expenditures of $137.40M produced free cash flow of $3.28B.
How much debt does DR Horton have?
The balance sheet dated Sep 30, 2025 reported long-term debt of $5.97B, short-term debt of $5.97B and cash and equivalents of $2.99B.
DHI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors